Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Formation and disruption of functional domains in myelinated CNS axons.
Alemtuzumab in the treatment of multiple sclerosis: patient selection and special considerations.
Common genetic variants in the plasminogen activation pathway are not associated with multiple sclerosis.
Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors.
The influence of sulthiame on EEG in children with benign childhood epilepsy with centrotemporal spikes (BECTS).
Atypical inflammatory demyelinating syndromes of the CNS.
A combined NMR and molecular dynamics simulation study to determine the conformational properties of rat/mouse 35-55 myelin oligodendrocyte glycoprotein epitope implicated in the induction of experimental autoimmune encephalomyelitis.
Multiple sclerosis: Dehydration might contribute to fatigue in MS.
Thrombomodulin dependent protein C activation is required for mitochondrial function and myelination in the CNS.
Renin-angiotensin system gene expression and neurodegenerative diseases.
Disease activity in chronic inflammatory demyelinating polyneuropathy.
Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkers.
Age-Related Changes in Axonal and Mitochondrial Ultrastructure and Function in White Matter.
Patients smoking cannabis are risking their health.
Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis.
T-bet promotes the accumulation of encephalitogenic Th17 cells in the CNS.
Current status of biomarker research in neurology.
BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset.
Orderly Steps in Progression of JC Virus to Virulence in the Brain.
Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Haematopoietic stem cell transplantation in autoimmune diseases: From basic science to clinical practice.
Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor Cells.
MHC class II isotype- and allele-specific attenuation of experimental autoimmune encephalomyelitis.
Kynurenic Acid Induces Impairment of Oligodendrocyte Viability: On the Role of Glutamatergic Mechanisms.
Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
Pages
« first
‹ previous
…
771
772
773
774
775
776
777
778
779
…
next ›
last »